System Transmission

Top Signal

100#1 JOB

Activity

2168Ripe

+924 today

System

Livenow

Terminal Asset View

stockNASDAQ

MRKR

$1.33-1.48%

Marker Therapeutics Inc

Neutral

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

35Neutral

Live Analysis Active

Company Mission

Marker Therapeutics develops cell-based therapies that use a patient's own immune cells to fight cancer. These treatments are being tested in clinical trials for patients with various cancers. The company earns money through research funding, grants, and partnerships with larger pharmaceutical companies that help develop and potentially commercialize these therapies.

MRK

Industry Context

Biotechnology companies focus on developing medical treatments using advanced science. This sector sees high interest when new therapies show promise in clinical trials, but can be volatile as investors wait for research results.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

77Matrix

Market Momentum

40.1— Holding Steady

Trend Strength

25— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

0.6x— Normal Volume

Today's Change

-1.48%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing MRKR across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 04:01 AM UTC

As-of 03-15-2026 03:46 UTC

Develops cancer treatments using immune cells and makes money by licensing its technology to pharmaceutical companies.

Price below key moving averages, suggesting a downtrend caution as sellers have maintained control over recent weeks showing consolidation pattern.

Technical squeeze detected near current levels, indicating potential breakout when price volatility expands from this tight range, suggesting tight.

Educational only. Not investment advice.

Precision Intelligence Model

Live Terminal Stream

Loading chart...